Receiving the FDA’s clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8527 ...

Considering taking supplements to treat sinonasal polyposis? Below is a list of common natural remedies used to treat or reduce the symptoms of sinonasal polyposis. Follow the links to read common ...

The trial will focus on patients with Familial Adenomatous Polyposis (FAP), indicating the company is addressing urgent medical needs in a high-risk patient population. This initiative is ...

"Small intestinal tumors are much rarer than those in the colon, but the risk is higher in cases of familial adenomatous polyposis," said lead researcher Hiroshi Ohno, from RIKEN IMS, in a statement.

Fast Track designation from the US FDA highlights the potential of eRapa to address a significant unmet medical need in treating Familial Adenomatous Polyposis (FAP), potentially expediting its ...

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP Biodexa is finalizing plans to initiate an international Phase 3 ...

The planned Phase 2 study will evaluate the efficacy and safety of TPST-1495 in patients with Familial Adenomatous Polyposis (FAP) who have previously undergone colectomy. The primary efficacy ...